首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >'In-loop' F-18-fluorination: A proof-of-concept study
【24h】

'In-loop' F-18-fluorination: A proof-of-concept study

机译:“环绕”F-18氟化:概念验证研究

获取原文
获取原文并翻译 | 示例
           

摘要

There is a great demand to develop more cost-efficient and robust manufacturing processes for fluorine-18 (F-18) labelled compounds and radiopharmaceuticals. Herein, we present to our knowledge the first radiofluorination "in-loop," where [F-18]triflyl fluoride was used as the labelling agent. Initial development of the "in-loop" [F-18]fluorination method was optimized by reacting [F-18]triflyl fluoride with 1,4-dinitrobenzene to form [F-18]1-fluoro-4-nitrobenzene. This methodology was then applied for the syntheses of two well-known radiopharmaceuticals, namely, [F-18]T807 for imaging of tau protein and [F-18]FEPPA for imaging the translocator protein 18 KDa. Both radiotracers were synthesized and formulated using an automated radiosynthesis module with nondecay corrected radiochemical yields of 27% and 29% (relative [F-18]F-), respectively. The overall syntheses times for [F-18]T807 and [F-18]FEPPA were 65 and 55 minutes, respectively. In these cases, our "in-loop" radiofluorination methodology enabled us to obtain equal or superior yields compared with conventional reactions in a vial. The radiochemical purities were more than 99%, and the molar activities were more than 350 GBq/mu mol at the end-of-synthesis for both radiotracers. This novel method is simple, efficient, and allows for a reliable production of radiofluorinated compounds and radiopharmaceuticals.
机译:有一种很大的需求,可以为氟-18(F-18)标记化合物和放射性药物制造更具成本效益和鲁棒的制造工艺。在此,我们展示我们的知识第一个酰胺“环中”,其中使用[F-18]甲纤维氟化物作为标记剂。通过使[F-18]氟化物与1,4-二硝基苯反应形成[F-18] 1-氟-4-硝基苯,优化“环环”[F-18]氟化方法的初始开发。然后将该方法施用于两个众所周知的放射性药物的合成,即[F-18] T807用于成像的Tau蛋白和[F-18] FEPPA,用于成像易偶蛋白18kDa。使用自动辐射合成模块合成并配制了两种反辐射体,分别使用自动辐射合成模块配制,分别具有27%和29%(相对[F-18] F-)的Nondecay校正的放射化学产率。 [F-18] T807和[F-18] FEPPA的总合成时间分别为65和55分钟。在这些情况下,我们的“环环”辐射氟化方法使我们能够获得与小瓶中的常规反应相比的平等或优越的产率。放射化学纯度大于99%,摩尔活性在含有反馈基机的合成结束时大于350gbq / mumol。这种新方法简单,高效,并且允许可靠地生产含射氟化碳化合物和放射性药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号